Activity of Antioxidant System in Patients with Uterine Fibroids
DOI:
https://doi.org/10.61841/qnya7v75Keywords:
Activity of Antioxidant, Uterine Fibroids, Growth and DivisionAbstract
Uterine fibroids are one of the most common benign tumors of the female reproductive system [1]. According to modern concepts, uterine fibroids are defined as a benign, non-specific hyperplastic process in the myometrium, in the pathogenesis of which a number of factors take part [2]. Nowadays the hormonal theory in the etiology of the growth and occurrence of uterine fibroids is the most relevant [3]. A number of authors connect the growth of fibroids with an increased level of estrogen that develops in the tissues of the tumor itself [4]. Recently, the role of endogenous intoxication as the main pathogenic mechanism of the development of this disease has been studied in detail. Researches aimed at studying this problem prove that all the main pathophysiological manifestations of endogenous intoxication are determined by a destruction of structural and functional organization of the membranes, which ultimately leads to destabilization and disruption of cell growth and division.
Downloads
References
[1] Dobrohotova Ju.Je., Ibragimova D.M., Saprygina L.V. Uterine fibroids.-M.: GJeOTAR –Media. 2018.-96 s
[2] Kohanevich E.V., Vovk I.B., Povoroznjuk V.V. i dr. Actual issues of gynecology. - K.: OOO «Knigapljus»,2013.-S.», 2013.-S. 103-119
[3] Banin V.V. Endogenous intoxication: Abstracts of the international symposium.-.S.-Sb.-2015.-S.10-17.
[4] Sidorova I.S., Ardus N.V. Modern pathogenetic aspects of uterine fibroids // Rossijskij vestnik akushera –ginekologa. 2014-№3.- S. 26 -29.
[5] Bassalyk L.S. Steroid hormone receptors in human tumors. – M., 2013. – 211s.
[6] Vladimirov Ju.A. The role of violations of the barrier and matrix functions of the lipid bilayer of biological membranes in pathology // Aktovaja rech'. – M., 2015. – S.27 – 30.
[7] Narzykulova S.A. “Risk factors for the occurrence of uterine” Tashkent, 2013.—S. 314–316.
[8] Islamova M.N. The use of amben, emoxipin and dimephosphone in the complex treatment of patients with uterine myoma, complicated by bleeding //Vestnik RUDN, serija Medicina-2017-№7. -S.219-223
[9] Savickij G.A., Pavlovich V.G. Some features of the contractility of the myometrium with uterine fibroids // Akush. i ginek. – 2014.-S.30 – 33.
[10] Lipatova N.A. Study of lipid metabolism in patients with uterine myoma with hysterectomy. //Jelektronnyj
nauchno-obrazovatel'nyj vestnik Zdorov'e i obrazovanie v XXI veke -№11.-2016.-T.10-S.470-471
[11] Vihljaeva E.M. "On the strategy and tactics of managing patients with uterine myoma." . – 2016.-N 3. – S.21 -23
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
